ArticleBlood advances2022

Venetoclax enhances the efficacy of therapeutic antibodies in B-cell malignancies by augmenting tumor cell phagocytosis.

Fotini Vogiatzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.